These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 9084705)

  • 21. Early administration of the second dose of surfactant (beractant) in the treatment of severe hyaline membrane disease.
    Figueras-Aloy J; Quero J; Carbonell-Estrany X; Ginovart G; Pérez-Rodríguez J; Raspall F; Rodríquez Miguélez JM; Salvía MD
    Acta Paediatr; 2001 Mar; 90(3):296-301. PubMed ID: 11332171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Neonatal respiratory distress syndrome treated with a natural surfactant. The Norwegian Curosurf study].
    Saugstad OD; Danielsen K; Grønn M; Holt J; Meberg A; Silberg IE; Okland O
    Tidsskr Nor Laegeforen; 1993 Aug; 113(19):2389-93. PubMed ID: 8378900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nasal continuous positive airway pressure and early surfactant therapy for respiratory distress syndrome in newborns of less than 30 weeks' gestation.
    Verder H; Albertsen P; Ebbesen F; Greisen G; Robertson B; Bertelsen A; Agertoft L; Djernes B; Nathan E; Reinholdt J
    Pediatrics; 1999 Feb; 103(2):E24. PubMed ID: 9925870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Early regular versus late selective poractant treatment in preterm infants born between 25 and 30 gestational weeks: a prospective randomized multicenter study.
    Dilmen U; Özdemir R; Tatar Aksoy H; Uras N; Demirel N; Kırimi E; Erdeve Ö; Özer E; Baş AY; Gürsoy T; Zenciroğlu A; Ovalı F; Oğuz ŞS
    J Matern Fetal Neonatal Med; 2014 Mar; 27(4):411-5. PubMed ID: 23795582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of acute phase response and infection. The role of procalcitonin and C-reactive protein.
    Rothenburger M; Markewitz A; Lenz T; Kaulbach HG; Marohl K; Kuhlmann WD; Weinhold C
    Clin Chem Lab Med; 1999 Mar; 37(3):275-9. PubMed ID: 10353472
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Uptake and degradation of Curosurf after tracheal administration to newborn and adult rabbits.
    Alberti A; Pettenazzo A; Enzi GB; Palamidese A; Mapp C; Ventura P; Baritussio A
    Eur Respir J; 1998 Aug; 12(2):294-300. PubMed ID: 9727777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dextran or polyethylene glycol added to curosurf for treatment of meconium lung injury in rats.
    Lu KW; Robertson B; Taeusch HW
    Biol Neonate; 2005; 88(1):46-53. PubMed ID: 15767742
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Is there a necessity for multiple doses of surfactant for respiratory distress syndrome of premature infants?
    Tsakalidis C; Giougki E; Karagianni P; Dokos C; Rallis D; Nikolaidis N
    Turk J Pediatr; 2012; 54(4):368-75. PubMed ID: 23692717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ventilation-perfusion relationships in preterm infants after surfactant treatment.
    Bowen W; Martin CR; Krauss AN; Auld PA
    Pediatr Pulmonol; 1994 Sep; 18(3):155-62. PubMed ID: 7800432
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Surfactant treatment of newborn infants receiving continuous positive airway pressure treatment].
    Andersen T; Holm HS; Kamper J
    Ugeskr Laeger; 2006 Oct; 168(43):3723-7. PubMed ID: 17069738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of patent ductus arteriosus after exogenous surfactant in baboons with hyaline membrane disease.
    Shimada S; Raju TN; Bhat R; Maeta H; Vidyasagar D
    Pediatr Res; 1989 Dec; 26(6):565-9. PubMed ID: 2602035
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Natural and synthetic surfactant in the treatment of neonatal respiratory distress syndrome].
    Bratlid D; Farstad T
    Tidsskr Nor Laegeforen; 1994 Jan; 114(1):33-6. PubMed ID: 8296279
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modifications of surfactant phospholipid pattern in premature infants treated with curosurf: clinical and dietary correlations.
    Haumont D; Rössle C; Clercx A; Spehl M; Biver A; Richelle M; Carpentier YA
    Biol Neonate; 1992; 61 Suppl 1():37-43. PubMed ID: 1391264
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of single dose surfactant on pulmonary function.
    Bhat R; Dziedzic K; Bhutani VK; Vidyasagar D
    Crit Care Med; 1990 Jun; 18(6):590-5. PubMed ID: 2111754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The late administration of surfactant.
    Ballot DE; Rothberg AD; Davies VA
    S Afr Med J; 1995 Jul; 85(7):644-6. PubMed ID: 7482080
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Protective and curative effects of prophylactic administration of pulmonary surfactant on neonatal respiratory distress syndrome].
    Chu GL; Wang J; Xin Y; Zheng J; Zheng RX; Bi DZ
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(13):876-80. PubMed ID: 16759511
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study.
    Lamboley-Gilmert G; Lacaze-Masmonteil T;
    Paediatr Drugs; 2003; 5(9):639-45. PubMed ID: 12956620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Static respiratory compliance in the newborn. III: Early changes after exogenous surfactant treatment.
    Stenson BJ; Glover RM; Parry GJ; Wilkie RA; Laing IA; Tarnow-Mordi WO
    Arch Dis Child Fetal Neonatal Ed; 1994 Jan; 70(1):F19-24. PubMed ID: 8117122
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.